Christoph Krähenbühl of Excellis Health discusses the steps virtual pharma companies can take to help get their product to market.
Virtual
Virtual pharma companies characterised by small, agile and innovation-led operations have traditionally partnered with - or even been absorbed by - much bigger players in order to get their product to market.
Relying on the resources and expertise of these partners has been an essential part of their journey beyond the pure science - from getting through regulatory processes, clinical trials and manufacturing right through to marketing, supply chain design, sales, distribution and all the other post-launch activities.